These cells express the integrins CD103 and CD49a and the C-type lectin CD69, and are characterized by in situ proliferation, location and persistence in close contact with malignant cells, via binding of CD103 to tumor E-cadherin (35). This evidence concerns the gene CD69 and neoplasm.